BlackRock’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $116K | Sell |
|
|||||
|
2022
Q2 | $411K | Buy |
|
|||||
|
2022
Q1 | $899K | Sell |
|
|||||
|
2021
Q4 | $1.79M | Buy |
|
|||||
|
2021
Q3 | $1.61M | Buy |
|
|||||
|
2021
Q2 | $1.81M | Sell |
|
|||||
|
2021
Q1 | $4.22M | Buy |
|
|||||
|
2020
Q4 | $4.01M | Buy |
|
|||||
|
2020
Q3 | $3.98M | Buy |
|
|||||
|
2020
Q2 | $4.98M | Buy |
|
|||||
|
2020
Q1 | $3.28M | Sell |
|
|||||
|
2019
Q4 | $6.11M | Buy |
|
|||||
|
2019
Q3 | $3.83M | Buy |
|
|||||
|
2019
Q2 | $11.7M | Buy |
|
|||||
|
2019
Q1 | $430K | Buy |
|
|||||
|
2018
Q4 | $79K | Buy |
|